← back to search

David Liu

Bond University · AU
Area of research
Surgery · Hepatology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Total Knee Arthroplasty Outcomes, Orthopaedic implants and arthroplasty, and Healthcare Technology and Patient Monitoring.
h-index
58
citations
15,020
works
459
NIH funding
primary concept
email

Recent publications

Combination and Optimal Sequencing of Systemic and Locoregional Therapies in Hepatocellular Carcinoma: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel
Journal of Vascular and Interventional Radiology 2024cited by 7position: lastdoi
[Regulatory mechanisms and assessment of coronary artery calcification: a review].
PubMed 2024cited by 0position: lastdoi
Low-Dose vs Standard Warfarin After Mechanical Mitral Valve Replacement: A Randomized Trial
The Annals of Thoracic Surgery 2023cited by 38position: middledoi
Ablative Therapies for Localized Primary Renal Cell Carcinoma
Société Internationale d’Urologie Journal 2022cited by 13position: middledoi
International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres
European Journal of Nuclear Medicine and Molecular Imaging 2021cited by 245position: middledoi
Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors
Journal of Hematology & Oncology 2021cited by 141position: middledoi
Multi-Dimensional, Short-Timescale Tablet-Based Quantification of Movement Disorder Symptomatology (1445)
Neurology 2020cited by 0position: middledoi
Prevalence and treatment of opioid use disorders among primary care patients in six health systems
Drug and Alcohol Dependence 2019cited by 105position: middledoi
<sup>90</sup>Y Radioembolization for Hepatic Malignancy in Patients with Previous Biliary Intervention: Multicenter Analysis of Hepatobiliary Infections
Radiology 2018cited by 42position: middledoi
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
The Lancet 2017cited by 695position: middledoi
NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale
Contemporary Clinical Trials 2016cited by 61position: middledoi
Long‐term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi‐site trial
Addiction 2015cited by 214position: middledoi
Novel Pulse Oximetry Sonifications for Neonatal Oxygen Saturation Monitoring
Human Factors The Journal of the Human Factors and Ergonomics Society 2015cited by 24position: lastdoi
Effects of Tourniquet Use on Quadriceps Function and Pain in Total Knee Arthroplasty
Knee Surgery and Related Research 2014cited by 146position: firstdoi
Evaluation of the effect of information integration in displays for ICU nurses on situation awareness and task completion time: A prospective randomized controlled study
International Journal of Medical Informatics 2013cited by 81position: middledoi

Grants

Collaborative Research: CSR: Small: Systems Support for a Sustainable Smartphone Ecosystem
NSF2426352$300,0002025–2028PIRePORTER
Collaborative Research: CyberTraining: Pilot: Cyberinfrastructure-Enabled Quantum Computing Understanding Atomic Structures and Properties of Materials
NSF2417292$166,5152025–2026PIRePORTER
Collaborative Research: CNS Core: Large: Systems and Verifiable Metrics for Sustainable Data Centers
NSF2215016$364,9992022–2026PIRePORTER
CNS Core: Small: Language Runtime Support for Energy-Aware Applications
NSF1910532$478,5922019–2024PIRePORTER
SHF: Small: Lazy Data Structures for Data-Intensive Applications
NSF1815949$511,4022018–2023PIRePORTER
CRI: CI-New: Collaborative Research: Extensible, Software Enabled Unmanned Aerial Vehicles
NSF1823260$366,2512018–2022PIRePORTER
SHF: Small: Green Parallel Language Systems
NSF1526205$484,5472015–2019PIRePORTER
II: New: Collaborative Research: An Extensible Software Infrastructure for Unmanned Aerial Vehicles
NSF1512992$41,0752015–2017PIRePORTER
CAREER: Programming Models for Green Software
NSF1054515$479,3912011–2016PIRePORTER
CAREER: Expanding the Scope of Nucleic and Protein Evolution
NSF0094128$634,9062001–2005PIRePORTER
Mechanism of the Macrophage Response to Lymphokines
NSF8510469$110,0001985–1987PIRePORTER
Glycolipids: Macrophage Receptors For Migration Inhibitory Factor (Mif)
NSF8208262$177,6941982–1986PIRePORTER

Frequent collaborators

· 2 papers (2016–2017) · 2 papers (2016–2017) · 2 papers (2016–2017) · 2 papers (2016–2017)Nima Kokabi · University of North Carolina at Chapel Hill2 papers (2021–2024)Genie L. Bailey · Brown University2 papers (2016–2017)Patricia Novo · New York University2 papers (2016–2017)Sarah B. White · Medical College of Wisconsin2 papers (2018–2024)Joshua D. Lee · New York University2 papers (2016–2017)Walter Ling · University of California, Los Angeles2 papers (2015–2016)Abigail G. Matthews · Emmes (United States)2 papers (2015–2017)John Rotrosen · New York University2 papers (2016–2017)Edward V. Nunes · New York University2 papers (2016–2017)Marc Fishman · Conference Board2 papers (2016–2017) · 2 papers (2016–2017)Weijian Guo · Chinese Academy of Sciences1 papers (2021–2021) · 1 papers (2016–2016) · 1 papers (2021–2021)David J. Graham · The University of Texas Southwestern Medical Center1 papers (2014–2014)Liangjun Zhu · Nanjing Medical University1 papers (2021–2021)